These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Results of the Minnesota test in psoriasis patients. Preliminary note]. Piret JM; Hurel G; Bolgert M Bull Soc Fr Dermatol Syphiligr; 1967; 74(3):323-5. PubMed ID: 4383610 [No Abstract] [Full Text] [Related]
45. A psychiatric study of patients with regional enteritis. Ford CV; Glober GA; Castelnuovo-Tedesco P JAMA; 1969 Apr; 208(2):311-5. PubMed ID: 4388299 [No Abstract] [Full Text] [Related]
48. Some evidence of a relationship between Hodgkin's disease and intelligence. LESHAN L; MARVIN S; LYERLY O AMA Arch Gen Psychiatry; 1959 Nov; 1():477-9. PubMed ID: 14415971 [No Abstract] [Full Text] [Related]
50. Asthma of unknown origin as a psychological group. Resh MG J Consult Clin Psychol; 1970 Dec; 35(3):429. PubMed ID: 4395202 [No Abstract] [Full Text] [Related]
51. [Case of a prolonged (19 years) course of lymphogranulematosis]. Selivanova IP Probl Gematol Pereliv Krovi; 1972 Jan; 17(1):55-6. PubMed ID: 5020113 [No Abstract] [Full Text] [Related]
52. Our version of normal. Wood WA J Clin Oncol; 2010 May; 28(15):2648-9. PubMed ID: 20194833 [No Abstract] [Full Text] [Related]
53. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A; J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521 [TBL] [Abstract][Full Text] [Related]
54. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases. Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110 [TBL] [Abstract][Full Text] [Related]
55. [Psychological adjustment of patients with Hodgkin's lymphoma 5 years after completing treatment]. Rossi N; Baldaro B; Ercolani M; Lauria F; Rizzardi G Haematologica; 1982 Aug; 67(4):589-94. PubMed ID: 6815017 [No Abstract] [Full Text] [Related]
56. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy. Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397 [TBL] [Abstract][Full Text] [Related]
57. A randomized phase 2 study of PBPC mobilization by stem cell factor and filgrastim in heavily pretreated patients with Hodgkin's disease or non-Hodgkin's lymphoma. Stiff P; Gingrich R; Luger S; Wyres MR; Brown RA; LeMaistre CF; Perry J; Schenkein DP; List A; Mason JR; Bensinger W; Wheeler C; Freter C; Parker WRL ; Emmanouilides C Bone Marrow Transplant; 2000 Sep; 26(5):471-81. PubMed ID: 11019835 [TBL] [Abstract][Full Text] [Related]